Literature DB >> 32017221

Pediatric angioedema: Essential features and preliminary results from the Hereditary Angioedema Global Registry in Italy.

Mauro Cancian1, Francesca Perego2, Riccardo Senter1, Francesco Arcoleo3, Tiziana De Pasquale4, Alessandra Zoli5, Marco Cicardi2,6, Andrea Zanichelli7.   

Abstract

Isolated angioedema, which is a localized, non-pitting, and transient swelling of the subcutaneous or submucosal tissue not associated with pruritus, urticaria, or anaphylaxis, may be classified, based on genetic pattern and mediators, respectively, as acquired or hereditary and histamine- or non-histamine-induced. The pediatric population with C1-INH-HAE (Hereditary angioedema due to C1-inhibitor deficiency) is mostly symptomatic. The frequency of symptoms in such a population compared to adults seems to be lower, but we need more prospective data to conclude on this point. The HGR (Hereditary angioedema global registry), which collects symptoms in real time, will probably provide such information. In terms of treatments, pediatric patients are significantly disadvantaged due to the few studies aimed at registering treatment for this population.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  C1-inhibitor; HGR; ITACA; disease registry; hereditary angioedema; pediatric

Year:  2020        PMID: 32017221     DOI: 10.1111/pai.13170

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  3 in total

1.  Diagnosing Pediatric Patients With Hereditary C1-Inhibitor Deficiency-Experience From the Hungarian Angioedema Center of Reference and Excellence.

Authors:  Noémi Andrási; Zsuzsanna Balla; Beáta Visy; Ágnes Szilágyi; Dorottya Csuka; Lilian Varga; Henriette Farkas
Journal:  Front Allergy       Date:  2022-05-04

2.  Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor.

Authors:  P Triggianese; R Senter; A Petraroli; A Zoli; M Lo Pizzo; D Bignardi; E Di Agosta; S Agolini; F Arcoleo; O Rossi; S Modica; E Greco; M S Chimenti; G Spadaro; C De Carolis; M Cancian
Journal:  Front Med (Lausanne)       Date:  2022-09-14

3.  The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency.

Authors:  Andrea Zanichelli; Henriette Farkas; Laurance Bouillet; Noemi Bara; Anastasios E Germenis; Fotis Psarros; Lilian Varga; Noemi Andrási; Isabelle Boccon-Gibod; Marco Castiglioni Roffia; Michal Rutkowski; Mauro Cancian
Journal:  Clin Rev Allergy Immunol       Date:  2021-03-31       Impact factor: 8.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.